475 related articles for article (PubMed ID: 25431952)
1. H2AK119Ub1 and H3K27Me3 in molecular staging for survival prediction of patients with pancreatic ductal adenocarcinoma.
Chen S; Chen J; Zhan Q; Zhu Y; Chen H; Deng X; Hou Z; Shen B; Chen Y; Peng C
Oncotarget; 2014 Nov; 5(21):10421-33. PubMed ID: 25431952
[TBL] [Abstract][Full Text] [Related]
2. Snail recruits Ring1B to mediate transcriptional repression and cell migration in pancreatic cancer cells.
Chen J; Xu H; Zou X; Wang J; Zhu Y; Chen H; Shen B; Deng X; Zhou A; Chin YE; Rauscher FJ; Peng C; Hou Z
Cancer Res; 2014 Aug; 74(16):4353-63. PubMed ID: 24903147
[TBL] [Abstract][Full Text] [Related]
3. Histone H2AK119 Mono-Ubiquitination Is Essential for Polycomb-Mediated Transcriptional Repression.
Tamburri S; Lavarone E; Fernández-Pérez D; Conway E; Zanotti M; Manganaro D; Pasini D
Mol Cell; 2020 Feb; 77(4):840-856.e5. PubMed ID: 31883952
[TBL] [Abstract][Full Text] [Related]
4. Distinct dynamics and functions of H2AK119ub1 and H3K27me3 in mouse preimplantation embryos.
Chen Z; Djekidel MN; Zhang Y
Nat Genet; 2021 Apr; 53(4):551-563. PubMed ID: 33821005
[TBL] [Abstract][Full Text] [Related]
5. DNA methylome analysis identifies epigenetic silencing of FHIT as a determining factor for radiosensitivity in oral cancer: an outcome-predicting and treatment-implicating study.
Lin HY; Hung SK; Lee MS; Chiou WY; Huang TT; Tseng CE; Shih LY; Lin RI; Lin JM; Lai YH; Chang CB; Hsu FC; Chen LC; Tsai SJ; Su YC; Li SC; Lai HC; Hsu WL; Liu DW; Tai CK; Wu SF; Chan MW
Oncotarget; 2015 Jan; 6(2):915-34. PubMed ID: 25460508
[TBL] [Abstract][Full Text] [Related]
6. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
[TBL] [Abstract][Full Text] [Related]
7. High expression of trimethylated histone H3 at lysine 27 predicts better prognosis in non-small cell lung cancer.
Chen X; Song N; Matsumoto K; Nanashima A; Nagayasu T; Hayashi T; Ying M; Endo D; Wu Z; Koji T
Int J Oncol; 2013 Nov; 43(5):1467-80. PubMed ID: 23969945
[TBL] [Abstract][Full Text] [Related]
8. H2AK119ub1 guides maternal inheritance and zygotic deposition of H3K27me3 in mouse embryos.
Mei H; Kozuka C; Hayashi R; Kumon M; Koseki H; Inoue A
Nat Genet; 2021 Apr; 53(4):539-550. PubMed ID: 33821003
[TBL] [Abstract][Full Text] [Related]
9. Polycomb repressor complex 1 promotes gene silencing through H2AK119 mono-ubiquitination in acinar-to-ductal metaplasia and pancreatic cancer cells.
Benitz S; Regel I; Reinhard T; Popp A; Schäffer I; Raulefs S; Kong B; Esposito I; Michalski CW; Kleeff J
Oncotarget; 2016 Mar; 7(10):11424-33. PubMed ID: 26716510
[TBL] [Abstract][Full Text] [Related]
10. EZH2-induced H3K27me3 is associated with epigenetic repression of the ARHI tumor-suppressor gene in ovarian cancer.
Fu Y; Chen J; Pang B; Li C; Zhao J; Shen K
Cell Biochem Biophys; 2015 Jan; 71(1):105-12. PubMed ID: 25077680
[TBL] [Abstract][Full Text] [Related]
11. 4-Nonylphenol-enhanced
Ghosh K; Chatterjee B; Maheswari U; Athifa M; Kanade SR
Epigenomics; 2019 Jun; 11(8):899-916. PubMed ID: 31144530
[No Abstract] [Full Text] [Related]
12. The role of the polycomb repressive complex pathway in T and NK cell lymphoma: biological and prognostic implications.
Kim SH; Yang WI; Min YH; Ko YH; Yoon SO
Tumour Biol; 2016 Feb; 37(2):2037-47. PubMed ID: 26337274
[TBL] [Abstract][Full Text] [Related]
13. Genomic loss of EZH2 leads to epigenetic modifications and overexpression of the HOX gene clusters in myelodysplastic syndrome.
Xu F; Liu L; Chang CK; He Q; Wu LY; Zhang Z; Shi WH; Guo J; Zhu Y; Zhao YS; Gu SC; Fei CM; Li X
Oncotarget; 2016 Feb; 7(7):8119-30. PubMed ID: 26812882
[TBL] [Abstract][Full Text] [Related]
14. EZH2 represses target genes through H3K27-dependent and H3K27-independent mechanisms in hepatocellular carcinoma.
Gao SB; Zheng QF; Xu B; Pan CB; Li KL; Zhao Y; Zheng QL; Lin X; Xue LX; Jin GH
Mol Cancer Res; 2014 Oct; 12(10):1388-97. PubMed ID: 24916103
[TBL] [Abstract][Full Text] [Related]
15. Genomic context- and H2AK119 ubiquitination-dependent inheritance of human Polycomb silencing.
Shafiq TA; Yu J; Feng W; Zhang Y; Zhou H; Paulo JA; Gygi SP; Moazed D
Sci Adv; 2024 May; 10(19):eadl4529. PubMed ID: 38718120
[TBL] [Abstract][Full Text] [Related]
16. DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression.
Ning X; Shi Z; Liu X; Zhang A; Han L; Jiang K; Kang C; Zhang Q
Cancer Lett; 2015 Apr; 359(2):198-205. PubMed ID: 25595591
[TBL] [Abstract][Full Text] [Related]
17. Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin.
Li CH; To KF; Tong JH; Xiao Z; Xia T; Lai PB; Chow SC; Zhu YX; Chan SL; Marquez VE; Chen Y
Gastroenterology; 2013 May; 144(5):1086-1097.e9. PubMed ID: 23395645
[TBL] [Abstract][Full Text] [Related]
18. Global histone modification of H3K27 correlates with the outcomes in patients with metachronous liver metastasis of colorectal cancer.
Tamagawa H; Oshima T; Numata M; Yamamoto N; Shiozawa M; Morinaga S; Nakamura Y; Yoshihara M; Sakuma Y; Kameda Y; Akaike M; Yukawa N; Rino Y; Masuda M; Miyagi Y
Eur J Surg Oncol; 2013 Jun; 39(6):655-61. PubMed ID: 23523318
[TBL] [Abstract][Full Text] [Related]
19. Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma cells by regulating cell cycle and apoptosis.
Nakagawa S; Okabe H; Sakamoto Y; Hayashi H; Hashimoto D; Yokoyama N; Sakamoto K; Kuroki H; Mima K; Nitta H; Imai K; Chikamoto A; Watanabe M; Beppu T; Baba H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S667-75. PubMed ID: 23887863
[TBL] [Abstract][Full Text] [Related]
20. Molecular and pathological characterization of the EZH2 rs3757441 single nucleotide polymorphism in colorectal cancer.
Fornaro L; Faviana P; De Gregorio V; Vivaldi C; Paolicchi E; Masi G; Loupakis F; Sensi E; Lupi C; Fontanini G; Wang Y; Danesi R; Falcone A; Crea F
BMC Cancer; 2015 Nov; 15():874. PubMed ID: 26553291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
